(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SILCONAZYNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SILCONAZYNE

ST13

US500000077775356

Class

9

Filing

77775356

Registration

4029259

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

06/06/2024

Trademark type

Word

Nice classes

9

Filing date

07/07/2009

Registration date

09/20/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/17/2022

Last transaction

06/06/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/13/2011

First use in commerce

05/13/2011

Drawing code

4

Owner type

03

Owner location

Creedmoor, NC, US

Examiner

STEEL, ALYSSA PALADINO

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Applied Medical Technologies, Inc.
Applied Medical Technologies, Inc.

Representatives

Henry B. Ward, III Bradley Arant Boult Cummings LLP

Technical classification

Nice Classes

Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Laboratory filters

Publications

History of USPTO decisions and trademark events.

39 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/17/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/17/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/17/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/16/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

09/14/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/20/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/15/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/14/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/14/2017

E815

TEAS SECTION 8 & 15 RECEIVED

09/20/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

09/20/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/18/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

08/17/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/10/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/02/2011

IUAF

USE AMENDMENT FILED

07/28/2011

EISU

TEAS STATEMENT OF USE RECEIVED

07/28/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/28/2011

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2011

EX2G

SOU EXTENSION 2 GRANTED

03/01/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/01/2011

EXT2

SOU EXTENSION 2 FILED

02/16/2011

EEXT

SOU TEAS EXTENSION RECEIVED

02/16/2011

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/11/2010

EX1G

SOU EXTENSION 1 GRANTED

08/09/2010

EXT1

SOU EXTENSION 1 FILED

08/09/2010

EEXT

SOU TEAS EXTENSION RECEIVED

08/09/2010

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

02/23/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/01/2009

PUBO

PUBLISHED FOR OPPOSITION

12/01/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/23/2009

ALIE

ASSIGNED TO LIE

10/23/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2009

DOCK

ASSIGNED TO EXAMINER

10/05/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2009

NWAP

NEW APPLICATION ENTERED

07/10/2009

Continuous trademark protection

Get notified about every new filing that threatens SILCONAZYNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.